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REVIEW
Plasticity of differentiated cells in wound repair and tumorigenesis,
part II: skin and intestine
Joseph Burclaff and Jason C. Mills*
ABSTRACT
Recent studies have identified and begun to characterize the roles of
regenerative cellular plasticity in many organs. In Part I of our two-part
Review, we discussed how cells reprogram following injury to the
stomach and pancreas. We introduced the concept of a conserved
cellular program, much like those governing division and death, which
may allow mature cells to become regenerative. This program,
paligenosis, is likely necessary to help organs repair the numerous
injuries they face over the lifetime of an organism; however, we also
postulated that rounds of paligenosis and redifferentiation may allow
long-lived cells to accumulate and store oncogenic mutations, and
could thereby contribute to tumorigenesis.We have termed themodel
wherein differentiated cells can store mutations and then unmask
them upon cell cycle re-entry the ‘cyclical hit’model of tumorigenesis.
In the present Review (Part II), we discuss these concepts, and cell
plasticity as a whole, in the skin and intestine. Although differentiation
and repair are arguably more thoroughly studied in skin and intestine
than in stomach and pancreas, it is less clear how mature skin and
intestinal cells contribute to tumorigenesis. Moreover, we conclude
our Review by discussing plasticity in all four organs, and look for
conserved mechanisms and concepts that might help advance our
knowledge of tumor formation and advance the development of
therapies for treating or preventing cancers that might be shared
across multiple organs.
KEY WORDS: Dedifferentiation, Paligenosis, Plasticity,
Regeneration, Stem cells, Tumorigenesis
Introduction
In Part I of this Review (Burclaff and Mills, 2018), we discussed
how long-lived, largely post-mitotic secretory cells in the stomach
and pancreas can reprogram to re-enter the cell cycle after injury
following a seemingly remarkably conserved process that we have
termed paligenosis (Willet et al., 2018). We proposed that an
unfortunate consequence of long-lived cells having the potential to
undergo rounds of paligenosis and redifferentiation is that they
might accumulate and store mutations until a final tumor-initiating
mutation induces a dysplastic change that locks cells in a
proliferative, pre-cancerous state (Fig. 1C). We have proposed this
as the ‘cyclical hit’ model of tumorigenesis (Mills and Sansom,
2015; Saenz and Mills, 2018) and suggested that mature long-lived
cells should be considered as potential tumor cells of origin.
Historically, the search for which normal cells give rise to cancer
has focused largely on tissue stem cells (SCs) because they are the
most replicative, and rapid cell division correlates with an increased
risk for acquiring mutations (Fig. 1A). Differentiated cells had
not been thought to be involved in initiating tumorigenesis (White
and Lowry, 2015). However, here we discuss how recent data
implicating differentiated cells as contributors to cancer may help
explain: (1) how SCs, now considered relatively short-lived in some
tissues, can accumulate mutations over decades, i.e. mutations can
be stored in differentiated cells that are recruited back into the SC
state; (2) how organs without constitutive SCs (such as the pancreas)
might acquire cancer; and (3) why genome sequencing often reveals
numerous mutations in seemingly normal differentiated cells
surrounding the cancer cells, i.e. ‘normal’ cells may accumulate
mutations over decades of cyclical hits until one clone undergoes
paligenosis to re-enter the cell cycle and spawn a tumor.
In Part II of this Review, we expand our discussion of plasticity
and tumorigenesis to two well-studied, diverse organs: the skin and
intestines. Both have intricate and dynamic SC hierarchies and
undergo continuous full-tissue turnover, yet they differ in structure,
function, developmental origin and cell types. Recent studies have
uncovered numerous plastic events occurring in both organs,
including intricate interconversions (Box 1) among various SC
populations and dedifferentiation of mature cell types to a progenitor-
like or even embryonic-like state. The well-defined cell types and
array of lineage-tracing (Box 1) markers available within these organs
have pointed to plasticity at multiple levels. Thus, our picture of cell
interconversions and individual cell ontogenies in these organs is
somewhat at a ‘higher resolution’ than in the pancreas and stomach (as
discussed in Burclaff andMills, 2018). For example, in the intestines,
multiple molecular markers have identified possible progenitor and
quiescent SC (qSC) populations that can replace the constitutive
Lgr5+ SC, which themselves can be studied by several markers and
promoter tools, following injury. The availability of these molecular
tools in the skin and intestine has resulted in intricate experiments that
support a ‘cyclical hit’ model of tumorigenesis. In this model, cells
that carry mutations have left the SC niche to become progenitors,
qSCs or more differentiated cells, but can be recalled to the SC niche
(see Box 1 for a glossary of terms) following damage, introducing
potentially tumorigenic mutations into the SC niche (Fig. 1B).
Because SCs can arise from more differentiated cells, even tumors
derived directly from niche-residing SCs may have actually depended
on the plasticity of non-SCs ancestors of the current niche-residing SC
at one point in their development. In short, here we discuss how
comparing potentially conserved mechanisms for cellular plasticity
among different organ systems may uncover additional nuance and
perspective on how regeneration and tumorigenesis occur.
Skin
The skin is the largest organ in the body, primarily consisting of the
interfollicular epidermis (IFE) with hair follicles (HFs) as one of the
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major appendages. Early work in the skin found proliferating cells
along the IFE basement membrane (BM) (Pinkus, 1952) and in the
HFmatrix (Van Scott and Ekel, 1958). Christopher Potten later used
label-retention assays (Box 1) to show that slower-proliferating SCs
are surrounded by quickly proliferating progenitors in the basal IFE
(Potten, 1974), which improved our understanding of the skin
SC and progenitor populations. Similarly, Cotsarelis discovered
label-retaining SCs along the outer wall (bulge) of the HF
(Cotsarelis et al., 1990). It took another decade to prove that these
HF-SCs were multipotent and able to generate all lineages within
the skin using early lineage-tracing techniques (Oshima et al.,
2001). It is now known that there are at least two distinct IFE SCs
populations (Table 1) (Sada et al., 2016), with their progeny rising
through the epidermal layers of the stratified squamous epithelium
as they differentiate (Fuchs and Raghavan, 2002; Clayton et al.,
2007). Further lineage-tracing studies have shown that the HF and
IFE normally derive from functionally distinct SC populations
(Ghazizadeh and Taichman, 2001; Levy et al., 2005) and there
is additional SC diversity within the distinct HF compartments
(Jaks et al., 2010) (Fig. 2A). SCs within the HF bulge were first
functionally determined using histone-2B label retention (Box 1)
(Tumbar et al., 2004) and later found to express several distinctive
markers (Table 1). Progeny from these SCs move off the BM and
into the follicle matrix to become transit amplifying (TA) cells
(Box 1). Melanocyte SCs (Box 1) also reside in the bulge and give
rise to mature melanocytes, which migrate to the lower HF or the
IFE (Mort et al., 2015). At the bottom of the follicle, the hair germ
maintains distinct SCs that regenerate the follicle upon hair loss
(Ito et al., 2004). Growth signals from the mesenchymal dermal
papilla (Box 1) at the bottom of the HF are necessary for proper
bulge cell proliferation, (Greco et al., 2009; Rompolas et al., 2012),
although loss of dermal papilla can be experimentally rescued by
activation of β-catenin (Box 1) within the SCs (Deschene et al.,
2014). When transplanted, dermal papilla cells are sufficient to
induce new HF formation and growth within the epidermis (Oliver,
1970; Jahoda et al., 1984), which can also be partially recapitulated
with activated β-catenin (Gat et al., 1998). Above the bulge lies the
sebaceous gland (Box 1), with B lymphocyte-induced maturation
protein 1 (Blimp1)+ progenitors (Horsley et al., 2006) maintaining
the sebocyte (Schneider and Paus, 2010) population. The upper
ridge of the HF, the infundibulum, is maintained in part by cells with
elevated expression of leucine-rich repeats and immunoglobulin-
like domains 1 (Lrig1) that also contribute to the sebaceous gland
(Jensen et al., 2009; Page et al., 2013). Finally, the isthmus between
the upper bulge and the sebaceous gland houses heterogeneous
progenitors characterized by an array of markers (Table 1).
Plasticity in the skin
The various regions in each HF compartment had largely been
studied in isolation, yet it is now clear that the progenitor and
differentiated cells are capable of considerable plasticity. HF SCs
continuously change proliferative state throughout the hair-cycle
phases of anagen (growth), catagen (retraction) and telogen (rest)
(Müller-Röver et al., 2001; Fuchs, 2009). HF SCs convert between
these active and quiescent states based on their distance from the
dermal papilla (Greco et al., 2009), with dynamic chromatin
remodeling regulating their ability to transition between phases
while maintaining cell identity (Lien et al., 2011).
The recent advent of intravital microscopy (Box 1) has greatly
facilitated skin plasticity studies (Park et al., 2016). Although
intravital imaging can be used in internal organs such as the
intestine (Ritsma et al., 2014), the skin is far more accessible,
Box 1. Glossary
APC: adenomatous polyposis coli protein. Negatively regulates β-catenin-
mediated Wnt signaling.
β-catenin: predominantly a cytoskeleton-associated protein that can
also relocate to the nucleus to transduce Wnt signaling.
Crestin: a marker normally seen in embryonic neural crest cells of
zebrafish. It is re-expressed in dedifferentiated melanocytes preceding
melanoma formation.
Crypt: also known as crypt of Lieberkühn. The deepest, invaginated,
portion of the small intestine and colonic epithelium, where all homeostatic
intestinal proliferation occurs.
Dermal papilla: small bud of the uppermost layer of the dermis; extends into
the base of the hair follicle to provide nourishment and signaling molecules.
Ectopic: in an abnormal location.
Hedgehogsignaling:acellular signaling pathway involved indifferentiation.
Hedgehog (Hh) ligands are received by the Patched receptor, which allows
Smoothened to accumulate andmodulate downstream transcription factors.
Interconversion: plasticity involving one stem cell population switching
their identity to become a separate stem cell population.
Intravital microscopy: microscopy in living animals allowing
for observation of biological processes in vivo. Also known as ‘live
imaging’.
Label-retention assays: experimental techniques that use radioactivity
or other tracers to mark the DNA of cells. The label becomes diluted as
cells divide and disperse their DNA between daughter cells. Label-
retaining cells (LRCs) maintain their labeling for extended periods of
time, indicating that they divided at least once to incorporate label, but did
not divide frequently thereafter, so their DNA retained the label, which
indicates that the cells are slowly dividing.
Lineage tracing: experiments to determine all progeny from a specific
cell. Uses cell-specific promoter genes to express reporter genes in
target cells and their progeny.
Melanocyte stem cells: stem cells that originate from neural crest cells
that migrate into the bulge during development and give rise to mature
melanocytes that generatemelanin (pigment), generally for the hair and skin.
Nude mice: mice that have an inhibited immune system as they are
congenitally athymic and therefore produce a greatly reduced number of
T cells.
Ras superfamily: a gene family encoding for small GTPase proteins
that transmit signals when activated, often promoting genes involved
in cell growth and survival. HRAS, KRAS and NRAS are commonly
mutated in human cancers (Downward, 2003).
Sebaceous gland: a small gland attached to the top of the hair follicle
containing lipid-rich, sebum-producing sebocytes to lubricate the skin
and hair.
Stem cell niche: an area of tissue in which stem cells reside and which
provides the necessary nutrients and signals to keep them in an
undifferentiated and self-renewing state.
Suprabasal: above the basal layer. In the interfollicular epidermis, this
term implies that the cell is differentiated, not a basal stem cell or progenitor
cell.
Transit amplifying (TA) cells: rapidly proliferating cells with limited
potential to give rise to other cell types, i.e. they produce daughter
cells for differentiation but cannot self-renew more than a few times. TA
cells are found in hair follicles, intestinal crypts and hematopoietic
niches.
Two-photon live imaging: the use of two-photon microscopy in living
organisms (e.g.mice), allowing for live imagingof tissue up to 1 mm in depth.
Villi: epithelial projections extending into the intestinal cavity. Intestinal
villi maximize the surface area of nutrient-absorbing enterocytes.
Wnt signaling: a signaling pathway controlling cell fate and proliferation,
among other processes. Wnt ligands are bound by the Frizzled receptor,
which in turn stops a complex containing APC from degrading β-catenin.
If free (non-cytoskeleton-associated) β-catenin accumulates, it relocates
to the nucleus to coordinate gene transcription events characteristic of
the Wnt response. Thus, deficient APC or constitutively active β-catenin
potentiate the transcriptional output of active Wnt signaling.
Xenografts: tissue or tumor transplanted from a donor to a host of a
different species, i.e. human tumor cells transplanted into a mouse.
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allowing for rapid advances in our knowledge of skin-cell
population dynamics. Greco and coworkers pioneered two-
photon live imaging (Box 1) (Rompolas et al., 2012) to demonstrate
that populations of SCs residing in different locations of the HF are
capable of interconverting upon injury: if the bulge or hair germ is
laser ablated, the remaining niche can repopulate the lost SCs and
regain full function (Rompolas et al., 2013) (Fig. 2B). This fits with
another study showing that CD34+ SCs in the upper bulge are able
to replace Lgr5+ SCs in the lower bulge and hair germ that are lost
upon targeted ablation (Hoeck et al., 2017). Similarly, the discrete
IFE SC populations can interconvert if one of them is ablated
(Sada et al., 2016).
As in other organs, injury changes the proliferative dynamics in
the skin (Donati and Watt, 2015). HF and IFE SCs maintain distinct
cellular populations at homeostasis (Levy et al., 2005). Upon
epidermal wounding, IFE SCs drive much of the regeneration
(Mascré et al., 2012), but follicular cells also aid in repopulating the
IFE, with cells from nearly all HF compartments streaming into the
wound bed (Ito et al., 2005; Page et al., 2013; Goodell et al., 2015).
Many of these cells are short-lived and are quickly replaced by IFE
cells, yet some HF-originating cells reprogram into long-lived IFE
progenitors following wounding, although it is unclear whether
these cells were originally SCs or more differentiated progeny (Levy
et al., 2007) (Fig. 2B). A recent study suggests that these changes are
driven by chromatin rearrangements within the SCs, which override
the normal SC homeostatic enhancers (Ge et al., 2017).
The dynamics of the migration to the wound bed have long been
debated (Headon, 2017). Skin may heal with a ‘wavefront’ model,
with cells migrating into the wound bed being led by the basal
progenitors (Radice, 1980; Safferling et al., 2013), or it could use a
‘leapfrog’ model with migration led by early differentiated cells
detaching from the BM, migrating, then dedifferentiating and
re-attaching to the BM at the wound bed (Krawczyk, 1971; Paladini
et al., 1996). Skin cells have long been considered unable to
dedifferentiate, supporting the wavefront model, and two recent
studies reinforce this conclusion (Aragona et al., 2017; Park
et al., 2017). However, another recent study from the Watt lab
demonstrates that, upon IFE puncture, Gata6+ cells from the
sebaceous gland migrate out from the HF suprabasally (Box 1)
then dedifferentiate and reattach to the BM at the wound site as
SCs (Fig. 2C) (Donati et al., 2017). The authors saw similar
dedifferentiation of Blimp1+ progenitors as well, leading to the
speculation that ‘dedifferentiation may be a general property of
terminally differentiated epidermal cells following wounding’
(Donati et al., 2017). It will be interesting to determine whether
skin cell dedifferentiation follows the conserved paligenosis pattern
involving early autophagy and dynamic mammalian target of
rapamycin complex 1 (mTORC1) regulation (Willet et al., 2018).
Skin tumorigenesis
The skin presents interesting opportunities for studying
tumorigenesis because it has been shown that phenotypically
healthy aged human skin harbors large (up to multiple square
millimeters) clones carrying numerous genomic mutations,
including known driver mutations associated with squamous cell
SC 
Injury
MutationNiche stem cell Cancerous cellNon-stem-cell
A  Canonical multi-hit model from stem cell
B  Cancer from stem cell following replacement
C  Cancer from non-stem-cell
Key
Fig. 1. Possible sources of tumor cells of origin. (A) The canonical multi-hit
model of tumorigenesis posits that stem cells (SCs) accumulate and store
the necessary mutations for tumors to initiate. The tumor would arise from the
normal SC niche and would not necessitate plasticity at any point to occur.
(B) Experiments in many tissues have demonstrated that SCs can be
replaced by more differentiated cells that revert to SCs and re-enter the niche.
This allows for mutations needed for tumor initiation to be acquired and
stored while the cell is in a non-SC fate (i.e. label-retaining cell, committed
progenitor, differentiated cell, etc.). This would appear as tumors arising from
the normal SC niche, yet would still incorporate earlier plasticity only visible
through careful tracking. (C) Tumors may also arise from non-SC populations
which never fully revert to a SC fate and re-enter the niche. Tumors arising
directly from mature cells would originate in a tissue area outside of the normal
SC niche.
Table 1. Common skin SC markers
Gene Location of SC marked Protein type Methods for visualizing References
Cd34 Bulge Surface marker IF, FACS Trempus et al., 2003
Krt19 Bulge Structural protein CreER allele, IF Youssef et al., 2010
Sox9 Bulge and hair germ Transcription factor EGFP allele, IF Kadaja et al., 2014
Krt15 Bulge and hair germ Structural protein Cre allele, IF Morris et al., 2004
Lgr5 Bulge and hair germ Surface receptor CreER or GFP alleles Jaks et al., 2008
Gli1 Bulge and hair germ Transcription factor lacZ allele, IF Brownell et al., 2011
Blimp1 Sebaceous gland Transcription factor GFP allele, IF Horsley et al., 2006
Lrig1 Infundibulum and isthmus Transmembrane protein YFP/lacZ allele, IF Jensen et al., 2009
MTS24 Isthmus Surface epitope IF Nijhof et al., 2006
Lgr6 Isthmus Surface receptor lacZ or EGFP/CreER alleles Snippert et al., 2010a
Dlx1 Interfollicular epithelium Transcription factor CreER allele Sada et al., 2016
Slc1a3 Interfollicular epithelium Amino acid transporter CreER allele Sada et al., 2016
Cd34, cluster of differentiation 34; Krt, keratin; Sox9, SRY-box 9; Lgr5/6, leucine-rich repeat-containing G-protein coupled receptor 5/6; Gli1, glioma-associated
oncogene homolog 1; Blimp1, B lymphocyte-induced maturation protein 1; Lrig1, leucine-rich repeats and immunoglobulin-like domains 1; MTS24, antibody
designation;Dlx1, distal-less homeobox 1; Slc1a3, solute carrier family 1 member 3; IF, immunofluorescence; FACS, fluorescence-activated cell sorting; CreER,
inducible Cre recombinase; GFP/YFP, green/yellow fluorescent protein; EGFP, enhanced GFP.
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carcinoma (SCC; Box 2) (Martincorena et al., 2015). Studies in
mice reinforce that skin cells can maintain mutations without
forming tumors: expressing constitutively active KrasG12D (see Ras
superfamily, Box 1) in Lrig1+ SCs at the infundibulum of the HF
does not induce tumors, unless the epidermis is wounded with a
biopsy punch (Page et al., 2013). This is similar to the finding that
KrasG12D is unable to drive pancreatic cancer without induced
inflammation (Guerra et al., 2007), as discussed in Part I of this
Review (Burclaff and Mills, 2018). This conserved need for
wounding highlights how mutations can be stored in the cellular
lineages long term, until some aspect of the recovery response, such
as changes within the SCs or in their progeny, initiates tumor
formation. Studies have shown that expression of numerous
oncogenes in various skin SCs can initiate tumors (Brown et al.,
1998; Youssef et al., 2010; Kasper et al., 2011; Wong and Reiter,
2011; Page et al., 2013), yet many studies have shown a requirement
for multiple hits, such as deletion of transforming growth factor-beta
receptor type 1 (Tgfbr1), replacing the effect of wounding to initiate
rapid tumor formation from bulge SCs primed with mutations in
the Ras pathway (Cammareri et al., 2016).
There is also evidence that multiple skin cancers (Box 2) can arise
through dedifferentiation (Song and Balmain, 2015). This was first
demonstrated in 1990, when the Balmain lab expressed mutant
Hras under the control of the keratin 10 (Krt10) promoter, whose
expression they showed to be constrained to suprabasal IFE cells
(i.e. more mature cells and not SCs). They supplied no experimental
second ‘hit’, yet still observed SCC formation at sites of frequent
wounding, such as the base of the tail and around the ear tags
(Bailleul et al., 1990). Thus, wounding was also necessary to
promote tumorigenesis in this system, akin to earlier experiments
showing that repeated mechanical injury (cutting) is sufficient to
promote tumor initiation in skin primed with a topical carcinogen
(Förstenberger et al., 1989) and in agreement with our understanding
of tumorigenesis in pancreas and stomach (Burclaff andMills, 2018).
Differentiated cells could also serve as cancer cells of origin when
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Fig. 2. The hair follicle (HF) and its responses to injury. (A) The healthy HF has many distinct compartments that each have stem cell (SC)
populations at the basal layer. These include the infundibulum at the top, the sebaceous gland, the isthmus, the bulge, and the hair germ at the bottom.
(B) Following full-thickness interfollicular epidermis (IFE) injury, cells from the HF aid in IFE recovery, even becoming long-lived IFE stem cells. Also, if
the bulge or hair germ is laser ablated, the remaining cells can interconvert to replace the missing cell populations. (C) Following epidermal injury,
progeny from Gata6+ or Blimp1+ sebaceous gland SCs exit the HF to aid in recovery. The cells migrate to the wound bed suprabasally, then dedifferentiate
and reattach to the basement membrane to act as SCs. CD34, cluster of differentiation 34; Krt, keratin; Sox9, SRY-box 9; Lgr5/6, leucine-rich repeat-
containing G-protein coupled receptor 5/6; Gli1, glioma-associated oncogene homolog 1; Blimp1, B lymphocyte-induced maturation protein 1; Lrig1,
leucine-rich repeats and immunoglobulin-like domains 1; mts24, antibody designation; Dlx1, distal-less homeobox 1; Slc1a3, solute carrier family 1
member 3.
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Krt1 promoter, which drives expression in suprabasal cells or
fate-determined, post-mitotic basal cells (Greenhalgh et al., 1993).
No recent studies have replicated expressing oncogenes inKrt1+ or
Krt10+ cells, as has been done for other skin SC populations, so
the potential contribution from unintended Hras signaling in other
cells in these original studies remains unknown. However, the
concept of plasticity in mature skin cells is supported by recent
results showing other suprabasal cells being recruited to act as
basal IFE SCs following injury (Donati et al., 2017). Future
experiments might target these populations with mutations other
than those in Ras genes, which are relatively uncommon in skin
cancers, and with better reporting techniques to ascertain whether
mutations more specific to skin cancer (Box 2) can initiate tumors
from non-SCs with or without wounding.
The Blanpain lab showed that another type of skin tumor, basal cell
carcinoma (BCC; Box 2) arises via dedifferentiation. They activated
Hedgehog signaling (Box 1) in long-lived IFE progenitor cells to
induce BCC in adult mice and found that the tumor-initiating cells
reprogrammed to a state resembling embryonic HF progenitors,
with high Wnt signaling (Box 1) and characteristic expression of
embryonic genes. They further confirmed that similarly elevated
Wnt activity and embryonic gene expression are present in human
BCC tissue samples (Youssef et al., 2012).
Several recent studies support a role for dedifferentiation in
melanoma initiation (Box 2). The first, by Kaufman et al.,
observed that melanoma arises from cells that first dedifferentiate
to an embryonic-like state. Zebrafish melanocytes with mutant,
constitutively active rapidly accelerated fibrosarcoma B
(BRAFV600E; Box 1) in a p53-null background become tumor-
initiating cells only after dedifferentiating to a state resembling
embryonic neural crest cells characterized by SRY-box 10 (sox10)
and crestin (Box 1) expression (Kaufman et al., 2016).
Two recent back-to-back articles used mouse models to analyze
how the melanocyte lineage gives rise to melanomas. Moon et al.
found that quiescent melanocyte SCs (MCSCs) in the HF bulge
were refractory to BrafV600E-driven tumorigenesis and depletion
of phosphatase and tensin homolog (Pten; Box 1), whereas
melanomas arose within the same genetic background following
MCSC activation by ultraviolet (UVB) radiation or drug-induced
inflammation (Moon et al., 2017). The cellular dynamics were further
analyzed by Köhler et al., who tracked the melanocytes shortly after
activation and found that MCSCs needed to differentiate and migrate
to the lower HF before being able to proliferate and initiate tumors,
with no increased proliferation seen directly from the bulge MCSCs
(Köhler et al., 2017). Further experiments using tumorigenesis
models in the mouse tail skin, which has features that more closely
mimic melanocyte location in human melanoma, again showed that
mature melanin-producing melanocytes could initiate melanoma,
while less mature amelanotic melanocytes were refractory to the
mutations. Finally, a third study described that cultured mature
melanocytes could be transformed into cancer-initiating cells by
overexpressing Fos-related antigen 1 (Fosl1). These cells formed
melanomas when injected into nude mice (Box 1; Maurus et al.,
2017), proving that such reprogramming can occur, at least in vitro.
Together, these studies demonstrate that mature melanocytes may act
as cells of origin for melanoma via dedifferentiation, and add to the
expanding literature indicating that dedifferentiation and plasticity
may play a key role in initiating multiple skin cancers.
Intestines
The intestines broadly comprise two principal histoanatomical
organizational patterns: (1) the small intestine, with crypts (Box 1)
extending towards the muscular wall, and villi (Box 1) extending
into the lumen; and (2) the large intestine, with a flat surface and
similarly invaginating crypts. Throughout, proliferation is confined
to the lower portions of the crypts, and most progeny move up
and out of the crypt as they differentiate, eventually sloughing off
and being replaced. Early studies found that the proliferating cells at
the crypt base include multipotent SCs able to produce all of the
intestinal cell lineages (Cheng and Leblond, 1974). The discovery
that Lgr5 expression marks these crypt-base columnar (CBC) SCs
(Barker et al., 2007) led to a rush of molecular work on intestinal cell
fate in the past decade. CBC cells reside in a niche that includes
epithelial Paneth cells and Foxl1+ mesenchymal cells beneath the
BM that support division and repress differentiation (Sato et al.,
2011; Roth et al., 2012; Aoki et al., 2016; Shoshkes-Carmel et al.,
2018). CBC daughters exit the crypt base and rise into the TA zone
in the middle/upper portion of the crypt, where the highest rates
of proliferation occur. Out of the milieu of stem and TA cells arise
the (largely) post-mitotic intestinal cell lineages: absorptive
enterocytes, antimicrobial-secreting Paneth cells, mucus-secreting
goblet cells, inflammation-coordinating tuft cells, and various
populations of enteroendocrine cells (Fig. 3A).
In addition to active CBC and TA cells, early studies also indicated
the existence of more slowly proliferating cells that survive to restore
intestinal crypts after radiation-induced death of the faster-cycling
populations (Hendry and Potten, 1974; Potten et al., 1974).
These cells were characterized as long lived and rarely dividing,
and were thus called label-retaining cells (LRCs) (Box 1).
Later experiments indicated that these were qSCs, which rarely
proliferate but are induced to do so upon injury (Li and Clevers,
2010). Many studies have used molecular markers and lineage
Box 2. The main types of skin cancer
The most common types of skin cancer are squamous cell carcinoma
(SCC), basal cell carcinoma (BCC) and melanoma. They arise through
varying molecular and cellular events and have different phenotypes and
prognoses.
BCC and SCC account for the vast majority of non-melanoma skin
cancer cases, and both arise from keratinocytes within the stratified
squamous skin epithelium. BCC and SCC tumors differ in many ways.
For one, grossly, BCC tumors appear smooth and translucent, whereas
SCC tumors are rough or scaly and fast growing. BCCs also rarely
metastasize, whereas SCC tumors can spread at a low but not
insignificant rate (Cakir et al., 2012). Ultraviolet (UVB) irradiation from
the sun promotes both tumor types (Gallagher et al., 2010), although
studies have indicated that childhood sun exposure is more important for
BCC, whereas SCC appears to be affected by total lifetime sun exposure
(Rosso et al., 1996; Zak-Prelich et al., 2004). Common mutations also
differ between the two. Over 70% of BCCs harbor mutations in Patched
or Smoothened, implicating the Hedgehog signaling pathway (Xie et al.,
1998), whereas SCC is more likely to exhibit mutations in p53 (Black and
Ogg, 2003). BCC and SCC also arise through different events, with BCC
tumors forming de novo from phenotypically undamaged skin and SCC
arising from precursor lesions or damage (McGillis and Fein, 2004). The
specific cells of origin for both remain unclear (Song and Balmain, 2015).
Melanomas are less frequent than SCC and BCC but also have the
highest predilection for metastasis. Unlike keratinocyte carcinomas,
melanomas arise from the melanocyte lineage, which originates from
embryonic neural crest cells. Melanomas are also promoted by sun
exposure, but genetic analysis indicates that UVA irradiation is more
important for melanomas than UVB (Wang et al., 2001). Although it is
clear that melanomas arise from cells within the melanocyte lineage, it
remains unclear at which level of differentiation the cells of origin need to
be to permit malignant transformation (Köhler et al., 2017; Moon
et al., 2017).
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tracing to characterize qSC populations residing around the +4 cell
position above the basal-most crypt cell and below the TA cells
(Fig. 3A). These label-retaining qSCs were originally considered
to be the ‘true’ intestinal SCs: they were believed to be mostly
quiescent and divide only rarely and always asymmetrically to
produce one SC daughter and one daughter that would
differentiate to other lineages (Potten et al., 1997).
There have been obstacles in definitively identifying these LRCs
and qSCs (Smith et al., 2016; Yousefi et al., 2017), including the
caveat that some transcripts expressed from gene promoters used
to mark qSCs [mouse telomerase (mTert)-GFP, B lymphoma
Mo-MLV insertion region 1 homolog (Bmi1)-CreER and HOP
homeobox (Hopx)-CreER] can be detected in all basal cells
(Itzkovitz et al., 2011; Muñoz et al., 2012; Li et al., 2014, 2016).
Additionally, some genes have been studied using different promoter
elements and mouse genetic approaches with divergent expression
patterns, such as Bmi1-CreER and Bmi1-EGFP (Li et al., 2014),
leading to conflicting results. Our current understanding of intestinal
qSCs is that they are distinct from LRCs, with qSCs remaining in the
quiescent G0 phase of the cell cycle (Li et al., 2016; Yousefi et al.,
2016), allowing for rapid cell cycle re-entry following injury, whereas
LRCs arrest in G1 and are suggested by some to be primarily Paneth
cells (Li et al., 2016). Several markers for qSCs have been proposed,
all of which are present in cells near the +4 crypt position, but some
appear to mark multiple distinct populations (Table 2). qSCs
occasionally give rise to CBC cells at homeostasis and more
frequently upon tissue injury, yet it is unclear whether CBC cells
commonly become qSCs (Li et al., 2014; Yousefi et al., 2017).
Intestinal SC populations can also be distinguished based on their
radiosensitivity: qISCs are largely radioresistant, perhaps owing to
their arrest in G0 (Montgomery et al., 2011; Yan et al., 2012; Li et al.,
2016), while mitotically active CBC cells are easily killed with
radiation (Yan et al., 2012; Tao et al., 2015), suggesting differential
sensitivity to DNA damage. The next section discusses how
dichotomous sensitivity to DNA damage may be a key feature of
plasticity within the intestines.
Intestinal plasticity
The interconversion between qSCs, marked by reporters driven by
Bmi1-CreER (Sangiorgi and Capecchi, 2008) or Hopx-CreER
(Takeda et al., 2011), and CBC cells has been demonstrated at
homeostasis, where lineage tracing revealed that qSC progeny can
give rise to all intestinal cells. In 2011, de Sauvage and coworkers
showed that, upon ablation, CBC cells can be replaced by
Bmi1-CreER-expressing qSCs (Tian et al., 2011). As mentioned
above, it is the Bmi1 transgene that specifically marks such cells,
not the endogenous mRNA or protein product (Muñoz et al.,
2012; Li et al., 2014). Numerous cell populations in various
differentiation states were subsequently shown to dedifferentiate
to replace the CBC cells following targeted ablation or irradiation
A  Healthy intestinal unit B  Unit following Lgr5 ablation
Crypt-base columnar SCs
























Sox9Hi, Dll1, Dclk1, 





Fig. 3. The intestinal crypt and its response to stem cell (SC) loss. The healthy intestinal unit, with SCs and Paneth cells (red) at the base, quiescent
SCs (qSCs) and label-retaining cells (LRCs) directly above those, then transit amplifying (TA) cells (teal). Above the crypt aremature enterocytes (blue) and goblet
cells (pink). Not shown: tuft cells and endocrine cells. Most proliferation occurs in the TA zone, with some at the crypt-base columnar (CBC) cells (green)
and infrequent proliferation of the qSCs/LRCs. (B) Many cells can replace the basal SC population following ablation, including interconversion of qSCs (brown)
and dedifferentiation of Paneth cell precursors, enteroendocrine cell precursors, goblet cell precursors, secretory progenitors and enterocyte progenitors (within
the yellow population). Lgr5, leucine-rich repeat-containing G-protein coupled receptor 5; Ascl2, achaete-scute family BHLH transcription factor 1; Olfm4,
olfactomedin 4; Smoc2, SPARC-related modular calcium binding 2; Troy, TNF receptor superfamily member 19; Lrig1, leucine-rich repeats and immunoglobulin-
like domains 1; Sox9, SRY-box 9; Bmi1, B lymphoma Mo-MLV insertion region 1 homolog; Hopx, HOP homeobox; mTert, mouse telomerase reverse
transcriptase; Prox1, prospero homeobox 1;Dll1, delta-like ligand 1; Alpi1, alkaline phosphatase, intestinal 1;Dclk1, doublecortin-like kinase 1; CreER, inducible
Cre recombinase.
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(Fig. 3B). These include the secretory lineage and/or Paneth cell
precursors (van Es et al., 2012; Buczacki et al., 2013; Roche
et al., 2015; Jadhav et al., 2017), enteroendocrine cell precursors
(Buczacki et al., 2013; Jadhav et al., 2017; Yan et al., 2017),
and absorptive enterocyte progenitors (Tetteh et al., 2016a).
However, targeted genetic ablation of Lgr5+ CBC cells with
concurrent irradiation causes extensive intestinal atrophy with
reduced regeneration (Metcalfe et al., 2014). These results are
consistent with two possible interpretations: that some portion
of Lgr5-expressing cells may survive irradiation and become
integral for the regenerative response (Metcalfe et al., 2014),
or that the cells that dedifferentiate to replace lost CBC cells
rapidly express enough Lgr5 to be targeted, and therefore
ablated, themselves. The mechanism for recruiting qSCs via
dedifferentiation is not well defined, yet yes-associated protein
1 (Yap1) is known to be required for proper regeneration
following irradiation (Gregorieff et al., 2015). The Lengner lab
demonstrated that Musashi (MSI) RNA-binding proteins and
mTORC1 activity are necessary and sufficient for qSCs to
re-enter the cell cycle (Yousefi et al., 2016, 2018). The latter
finding is particularly interesting given the key role that mTORC1
plays in paligenotic recruitment of mature gastric and pancreatic cells
to a proliferative state (Willet et al., 2018).
In addition to the aforementioned plasticity of qSCs and
progenitors, a recent report shows that irradiation can revert
mature Paneth cells to a proliferative state in which they give rise
to other intestinal lineages via a Notch1-mediated mechanism
(Yu et al., 2018). Paneth cells are close relatives to gastric chief
cells and pancreatic acinar cells (Burclaff and Mills, 2018), with all
three being large, long-lived, normally non-proliferative secretory
cells that express the transcription factor Mist1 (Lo et al., 2017).
The authors show that Yap1 is upregulated in these Paneth cells
as they dedifferentiate, although it has not yet been shown whether
they undergo the stages of paligenosis as seen in their gastric and
pancreatic counterparts (Willet et al., 2018).
Intestinal tumorigenesis
As with many adult cancers, the cell of origin for intestinal tumors
is actively debated (Huels and Sansom, 2015). Human intestinal
tumors frequently occur in a setting of adenomatous polyposis coli
(APC; Box 1) loss, active Wnt signaling and KRAS activation
(Lamlum et al., 2000). Most experimental tumorigenesis models
recapitulate those aberrations or express constitutively active
β-catenin to induce canonical Wnt signaling (Harada et al., 1999).
The canonical multi-hit theory (Vogelstein and Kinzler, 1993)
describes intestinal SCs as the cells of origin, as they were
considered a long-lived proliferative population that could thus
give rise to tumors (Fearon and Vogelstein, 1990; Vogelstein and
Kinzler, 1993). Consistent with this, ‘bottom up’ tumorigenesis,
i.e. originating from the crypt base, often occurs in humans, with
the earliest neoplastic cells seemingly originating from the crypt
(Preston et al., 2003). Similarly, APC deletion or expression of
stabilized β-catenin in CBC cells is sufficient for tumor initiation
in mice (Barker et al., 2009; Zhu et al., 2009). Mouse studies have
Table 2. Proposed intestinal SC markers
Marker Cell specificity Protein type
Methods for
visualizing References
Lgr5 CBC cells Surface receptor CreERT or GFP
alleles
Barker et al., 2007
Ascl2 CBC cells Transcription factor lacZ allele, ISH van der Flier et al., 2009
Olfm4 CBC cells Secreted glycoprotein EGFP/CreER allele,
ISH
van der Flier et al., 2009; Schuijers et al.,
2014
Smoc2 CBC cells Secreted matrix protein EGFP/CreER allele,
ISH
Munoz et al., 2012
Troy CBC cells Surface receptor CreER/EGFP allele Fafilek et al., 2013
Sox9-EGFP low CBC cells Transcription factor EGFP allele, IF Van Landeghem et al., 2012
Lrig1 CBC cells and basal qSCs Transmembrane protein YFP/lacZ allele, IF Powell et al., 2012; Wong et al., 2012
Bmi1-CreER +4 qSCs Component of polycomb
complex
CreER allele Sangiorgi and Capecchi, 2008
Hopx-CreER +4 qSCs Atypical homeobox protein CreER or lacZ alleles Takeda et al., 2011
mTert +4 qSCs Telomerase GFP or CreER alleles Montgomery et al., 2011
Sox9-EGFP high +4 qSCs Transcription factor EGFP allele, IF Van Landeghem et al., 2012;
Roche et al., 2015
Krt19 +4 qSCs and above Structural protein CreER allele, IF Asfaha et al., 2015
H2B label
retaining





GFP allele Yan et al., 2017
Prox1 Enteroendocrine lineage
qSCs
Transcription factor GFP allele, IF Yan et al., 2017
Dll1 Secretory lineage qSCs Surface signaler GFP/CreER allele,
ISH
van Es et al., 2012
Alpi Enterocyte lineage qSCs Brush border enzyme CreER allele, ISH Tetteh et al., 2016a
Dclk1 Tuft cell lineage qSC Protein kinase IHC May et al., 2008
Cd69+ Cd274+ Goblet cell precursor qSC Surface markers IF Jadhav et al., 2017
Lgr5, leucine-rich repeat-containing G-protein coupled receptor 5; Ascl2, achaete-scute family BHLH transcription factor 1; Olfm4, olfactomedin 4; Smoc2,
SPARC-related modular calcium binding 2; Troy, TNF receptor superfamily member 19; Lrig1, leucine-rich repeats and immunoglobulin-like domains 1;
Sox9, SRY-box 9; Bmi1, B lymphoma Mo-MLV insertion region 1 homolog; Hopx, HOP homeobox; mTert, mouse telomerase reverse transcriptase; Krt19,
keratin 19; H2B, histone H2B;Prox1, prospero homeobox 1;Dll1, delta-like ligand 1;Alpi, alkaline phosphatase, intestinal;Dclk1, doublecortin-like kinase 1; CBC,
crypt base columnar; IF, immunofluorescence; ISH, in situ hybridization; GFP/YFP, green/yellow fluorescent protein; EGFP, enhanced GFP; qSC, quiescent
stem cell.
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demonstrated that the CBC cells are not alone in their tumor-
generating capacity: constitutive β-catenin activation in Bmi1-CreER
qSCs (Sangiorgi and Capecchi, 2008) or APC deletion in Krt19+
qSCs (Asfaha et al., 2015) were both sufficient for tumorigenesis.
It should be noted that SCs rapidly give rise to other intestinal
epithelial cell types, so even though a tumor may arise in a scenario
where an oncogene is expressed in an SC, that doesn’t necessarily
mean that the last non-neoplastic cell before transition to cancer was
the SC itself. Thus, while the physical phenomenon of tumors
originating in crypts (i.e. ‘bottom up’) clearly occurs in both
humans and mice, it is currently difficult to ascertain whether such
tumors arise directly from the CBC cell itself or from its more
differentiated progeny. Moreover, as we know that numerous
populations can replace the CBC cell, it is possible that basal tumors
might originate from more differentiated daughters that regress back
into the crypt base after garnering neoplastic mutations (Fig. 1B).
Consistent with the role for plasticity in tumorigenesis in other
organs, evidence suggests that intestinal tumors can arise from
post-mitotic cells residing above the proliferative crypt, which
dedifferentiate and re-enter the cell cycle. ‘Top down’ tumorigenesis
(Shih et al., 2001) was noted in humans half a century ago, with
tumors observed at the tops of colon crypts detached from the base
(Cole and McKalen, 1963), although these were often attributed to
cutting artifacts or proliferating cells migrating from the crypt base
(Maskens, 1979). Mouse models later confirmed that differentiated
cells of the small intestine and colon can cause tumors in
experimental settings.
Injury and inflammation, specifically activated nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-κB) signaling,
are commonly associated with tumors, and two early experiments
used inflammation to induce tumorigenesis from non-proliferative
intestinal cells. In one such study, mature enterocytes formed
tumors on the villi when β-catenin and NF-κB were specifically
activated in them using the X-box-binding protein 1 (XBP1)
promoter (Schwitalla et al., 2013). In a parallel report, long-lived
colonic tuft cells lacking APC could form tumors only when
treated with the inflammatory agent dextran sodium sulfate (DSS)
(Westphalen et al., 2014). In yet another example where
dedifferentiation might be key, Tetteh et al. bypassed inflammation
and induced tumor formation in differentiated colon cells lacking
APC by forcing mutant Kras expression (Tetteh et al., 2016b),
demonstrating again that cells above the proliferative colonic crypt
can initiate tumorigenesis. Thus, these experiments are similar to
those described for skin, pancreas and stomach, wherein injury
causes differentiated cells to dedifferentiate (i.e. undergo paligenosis)
and unmask mutations as they re-renter the cell cycle that result
in tumorigenesis.
Other experiments in mouse models indicate how the ability to
maintain proper villus differentiation is important to avoid
tumorigenesis. Bone morphogenic protein (BMP) signaling
promotes normal crypt-villus differentiation, and expression of
the BMP antagonists noggin (Nog) (Haramis et al., 2004) or
gremlin 1 (Grem1) (Davis et al., 2015) in all intestinal cells via
the villin-1 (Vil1) promoter blocks differentiation and induces
tumor formation, with ectopic (Box 1) proliferative crypts
forming on villi perpendicular to the normal crypt plane. The
origin of these ectopic crypts is not clear, and they could arise via
dedifferentiation or from expansion of otherwise normal crypt
progenitors in an aberrant niche. Similar ectopic proliferative crypts
were observed upon Hedgehog (Box 1) inhibition (Madison et al.,
2005) or mesenchymal Bmpr1a knock out (Lim et al., 2017). Finally,
a recent study from the Sansom lab demonstrates that mice lacking
APC and Tgfbr1 while expressing mutant KrasG12D via the Vil1
promoter experience both ‘bottom up’ and ‘top down’ tumorigenesis.
They further show that MEK inhibition blocks tumorigenesis at the
villi but not the base (Cammareri et al., 2017). This suggests that
different mechanisms are likely involved in the different
compartments, even though the resulting tumors have surprisingly
similar genetic profiles. As MAPK signaling (downstream of MEK)
is necessary for gastric and pancreatic paligenosis (Collins et al.,
2014; Khurana et al., 2013), these results might also indicate that
blocking plasticity directly inhibits initiation of tumorigenesis in
differentiated cells, an effect that might be replicable across organs.
Although there are multiple potential instances of tumors arising
either directly from dedifferentiated (plastic) mature cells or from SCs
that developed from dedifferentiatingmature cells, all the studies have
caveats. Some lack lineage tracing to affirm the molecular features of
the tumor-initiating cells; many make inferences based on infrequent
tumor events, hampering generalization; and, in all cases, either
multiple mutations or tissue injury were required for tumor formation,
obfuscating the proximate cells of origin for the tumors. However, in
aggregate, the studies indicate that numerous cells aside from
crypt SCs can act as tumor cells of origin. As in other organs,
inflammation may induce cell plasticity, as is the case with DSS
causing inflammation and dedifferentiation in the intestine, possibly
mimicking how ulcerative colitis may increase the risk of colorectal
cancer in patients (Eaden et al., 2001). In short, injury-induced
intestinal plasticity may resemble the metaplasia/plasticity in
spasmolytic polypeptide-expressing metaplasia in the stomach and
acinar-to-ductal metaplasia in the pancreas [discussed in Part I of the
Review (Burclaff and Mills, 2018)] or in injuries that promote skin
tumors, as discussed above.
A role for plasticity has also been shown within established
intestinal malignancies. Lgr5Hi cells in tumors, defined by increased
Lgr5 transcript levels upon fluorescence-assisted cell sorting, are
often thought to maintain the SC features of Lgr5+ CBC cells
and are frequently regarded as stem-like cells for these tumors
(Merlos-Suárez et al., 2011). Cells with such properties have been
termed cancer SCs (CSCs) (Barker et al., 2009; Schepers et al.,
2012). Similar to intestinal CBC cells, recent studies demonstrate
that Lgr5Hi cells are not necessary for tumor maintenance. Lgr5Hi
cells in mouse colorectal tumors are replaceable upon targeted
ablation, although, intriguingly, they are necessary for liver
metastasis (de Sousa e Melo et al., 2017). Similar results occur
upon ablation of Lgr5Hi cells in human colorectal tumor xenografts
(Box 1), where cells expressing differentiation markers such as
keratin 20 (KRT20+) could regenerate the ablated Lgr5Hi tumor cell
population (Shimokawa et al., 2017). Even continued ablation of
Lgr5Hi cells in existing tumors using targeted antibody-drug
conjugates resulted only in smaller tumors and longer animal
survival, but not full recovery (Junttila et al., 2015). The ability of
tumors to recover from acute Lgr5Hi cell ablation and to slowly grow
even with constitutive loss of Lgr5Hi cells suggests that rounds of
dedifferentiation may continue even after tumor formation, perhaps
allowing for the accumulation of additional mutations that lead to
advanced tumor grades, metastasis or acquired resistance to therapy.
Conclusion
Plasticity is important in diverse organs, from the continuously
regenerating luminal gastrointestinal tract to the non-proliferative
pancreas (Burclaff andMills, 2018) and the highly compartmentalized
skin. It can manifest as focal interconversion of normally distinct SC
populations that is largely undetected outside of careful lineage
tracing, or as large-scalemetaplasia and dedifferentiation of long-lived
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mature cells. Cellular plasticity thus seems a critical feature of tissue
repair, but it is also clear that plasticity has the unfortunate side effect
of allowing tissues additional means to accrue, store and eventually
unmask oncogenic alterations that drive tumorigenesis.
In Part I of this Review, we discussed studies involving the
stomach and pancreas that support the ‘cyclical hit’ model of
tumorigenesis, with long-lived cells undergoing paligenosis and
then redifferentiating in response to environmental stimuli,
accumulating mutations until a final mutation locks them in a
proliferative state (Fig. 1C) (Burclaff and Mills, 2018). Studies from
the skin and intestine reviewed in the present article show that SCs
are replaced upon targeted ablation (Hsu et al., 2011; Tian et al.,
2011; Rompolas et al., 2013; Ritsma et al., 2014; Hoeck et al.,
2017). Interestingly, this may also occur in the stomach during
recovery of SC function following inhibition of proliferation (Radyk
et al., 2018). Thus, various cellular populations can revert to a SC
state following injury. The findings that even longer-lived, fully
differentiated Paneth cells can be called back into the SC niche
indicate how cycles of dedifferentiation and redifferentiation could
lead to the eventual accumulation, storage and unmasking of
mutations in the intestines (Yu et al., 2018), just as it might occur in
the pancreas and stomach (Fig. 1B). In fact, the ‘cyclical hit’ model
for mutation accumulation may be especially pertinent in
the intestine, where past experiments using very low doses of
radiation imply that cells at the crypt base undergo apoptosis in
response to even slight perturbations to their genomic DNA (Ijiri
and Potten, 1990; Potten and Booth, 1997; Potten, 1998). If CBC
cells are truly highly sensitive to DNA damage, they may actually
be unable to accrue mutations on their own, necessitating
replacement by other cells for any new ‘hit’ to be accumulated.
While intriguing, these older observations should be replicated
with modern lineage-tracing techniques to monitor how sensitive
to mutations the CBC cells (and possibly other SC populations)
actually are.
The skin currently has less clear examples of mature cell plasticity
leading to tumors than in gastrointestinal organs, yet the available
evidence supports that it may occur. Multiple investigators have
shown that melanocytes form melanomas via dedifferentiation, and
many plasticity markers characteristic of the stomach, pancreas and
intestine also become upregulated during this progression (Table 3).
It will be interesting to see whether melanocytes undergo the three
stages of paligenosis as seen in other dedifferentiating cell types.
Two reports detail the activation of Hras in non-SC populations of
the IFE driving tumor formation (Bailleul et al., 1990; Greenhalgh
et al., 1993), but the authors did not have lineage-tracing tools
available. It should be noted though, that, even with lineage tracing
such as Cre-recombinase-based studies, unintentional recombination
may occur in untargeted cells. It is thus imperative to carefully
identify and track the labeled cells with multiple concomitant
methods to help resolve the cell of origin in such studies (see a
brief discussion of caveats of lineage tracing in Saenz and Mills,
2018). Some instances of apparent plasticity highlighted via
lineage tracing may therefore simply be cases wherein a
differentiated cell promoter was expressed in a SC, thereby
making it appear as if there had been a conversion of a mature cell
to a SC phenotype.
Despite the current lack of consensus about how often mature
cells revert to progenitors in skin (outside of the earlier studies
before genetic lineage tracing and in the case of melanoma), recent
studies indicate that the skin is not exceptional in what seems to be a
universal tissue property. Specifically, in vivo live-imaging data
from the Watt lab support that dedifferentiation of suprabasal cells
may occur in the IFE (Donati et al., 2017). Also, even phenotypically
healthy aged skin appears to be a reservoir for cancer driver mutations
(Martincorena et al., 2015). This supports the possibility that
plasticity of cells of any differentiation state may unlock dysplasia-
causing mutations, as proposed in the latter stages of the cyclical hit
model (Fig. 1). SC lineage plasticity is also seen upon ablation of
specific populations of HF SCs, theoretically allowing mutations that
have accumulated in one population of SCs to then expand to another
compartment followingwounding, as the replacement SCs bring their
genome into the new SC niche. In short, there is evidence for various
kinds of cell plasticity in the skin, but which types occur frequently
and how they contribute to tumorigenesis is certainly still an open
Table 3. Common genes involved in plasticity of stomach, pancreas, skin and intestinal cell populations





Drives tumorigenesis Drives tumorigenesis Hingorani et al., 2005; Choi et al.,
2016; Raaijmakers et al., 2016;
Tetteh et al., 2016b
MAPK Required for SPEM Required for ADM Elevated in
reprogrammed
melanocytes
Increased in dedifferentiation Khurana et al., 2013; Collins
et al., 2014; Cammareri et al.,
2017; Köhler et al., 2017






Required for qSC function Sashikawa Kimura et al., 2011;
Prévot et al., 2012; Youssef
et al., 2012; Roche et al., 2015
YAP Increased in gastric
cancer
Required for ADM Elevated in
reprogrammed
melanocytes
Required for recovery from
irradiation and increased in
dedifferentiating Paneth cells
Gregorieff et al., 2015; Gruber
et al., 2016; Maurus et al.,
2017; Yu et al., 2017, 2018








Drives tumorigenesis Amiri and Richmond, 2005; Liou
et al., 2013; Schwitalla et al.,










Unknown Mature Paneth cell marker: role
in dedifferentiation unknown
Shi et al., 2009; Lo et al., 2017
MTORC1 Required for SPEM Required for ADM Required for proper
wound closure
Required for qSC activation Squarize et al., 2010; Willet et al.,
2018; Yousefi et al., 2018
RAS, rat sarcoma; MAPK, mitogen-activated protein kinase; SPEM, spasmolytic polypeptide-expressing metaplasia; ADM, acinar-to-ductal metaplasia; SOX9,
SRY-box 9; qSC, quiescent stem cell; YAP, yes-associated protein; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; Hp, Helicobacter
pylori; MIST1 (bHLHa15), class A basic helix-loop-helix protein 15; MTORC1, mammalian target of rapamycin complex 1; BCC, basal cell carcinoma.
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question. It is becoming clearer every day that tumorigenesis in other
organs involves mature cells being called back into a progenitor role,
which should provide an impetus to continue to investigate this type
of plasticity in skin.
In the present two-part Review, we have largely focused on cell-
autonomous events: cycles of paligenosis and redifferentiation
leading to cells that accumulate mutations that then drive those same
cells to become tumorigenic. On the other hand, plasticity might
intersect with tumorigenesis in non-cell-autonomous ways. It is
clear that benign neighbors in the skin and intestine can expel
potential cancer-forming cell clones (Brown et al., 2017; Kon et al.,
2017). It is possible that cycles of plasticity and mutations might
affect niche cells such that accumulated mutations block their ability
to stop malignant cells from expanding. In other words, the ‘final
hit’ mutation may not occur in a tumor’s cell of origin but rather in
the surrounding niche cells that have otherwise constantly been
suppressing the expansion of the tumorigenic cell (Burclaff and
Mills, 2017). For example, deletion of Tgfbr1 can replace the
requirement for tissue wounding to initiate tumors from bulge HF
SCs primed with RAS pathway mutations (Cammareri et al., 2016).
It is possible that, if cells surrounding a clone acquire mutations that
disrupt TGFβ signaling, then the clone that already harbors RAS
pathway mutations may be able to initiate a tumor without any
additional mutation load. In light of this ‘neighborhood watch’
mechanism of benign cells holding tumorigenic cells at bay, one
might also suppose that tumorigenesis might depend not only on the
tumor-initiating cells acquiring driver mutations in genes such as
Ras, but also on their acquiring mutations that allow them to escape
the vigilance of surrounding cells (Burclaff and Mills, 2017).
It is interesting to contemplate that, if plasticity of mature cells is
indeed a key shared aspect of tumorigenesis, there may be
opportunities to inhibit tumor initiation at the cell of origin for
adult-onset cancers in multiple organs. Of course, we are just
beginning tomap the landscape of the possible conservedmechanisms
that mediate the recruitment of mature cells back into the cell cycle.
Many signaling components are shared during the plasticity events
discussed in both parts of this Review (Table 2). As we continue to
advance our knowledge of plasticity mechanisms in these organs,
we will likely uncover additional parallels, potentially allowing for
development of therapeutics to prevent or reverse tumorigenesis across
many organs. Indeed, if the mechanisms governing paligenosis are
conserved across tissues, cell types and species, similarly to those
governing apoptosis, then our understanding of the molecular events
underlying tumor cells of origin might advance relatively quickly.
Although there is an obvious call to consider roles for mature
cells in cancer initiation, recent studies also suggest that we should
reconsider our notions about plasticity and CSCs in established
tumors. As mentioned above, the CSC model, as originally
articulated over a decade ago (Clarke et al., 2006), defined
CSCs as cells within tumors with the capacity to self-renew and to
propagate heterogeneous lineages of cancer cells. This definition
was largely based on the notions of normal tissue SCs being
long-lived (label-retaining) stable populations that undergo only
asymmetrical divisions resulting in unidirectional differentiation
of a single daughter cell, assumptions that have been called into
question (Lopez-Garcia et al., 2010; Snippert et al., 2010b). The
CSC model describes some tumors as depending on a distinct cell
population for their propagation, yet recent studies indicate that
putative CSCs can be replaced by other tumor cells that are capable
of plasticity (Merlos-Suárez et al., 2011; Junttila et al., 2015; de
Sousa e Melo et al., 2017; Shimokawa et al., 2017). Rounds of
dedifferentiation and reemergence of CSC attributes have also been
observed in several cultured cancer cell lines (Chaffer et al., 2011;
He et al., 2011). One perspective on these putative CSCs is that
tumors are actually composed of plastic populations with cells that
lose stemness and can be replaced by more ‘mature’ (or at least more
quiescent) populations within the tumor. If cancers partly arise via
reprogramming of mature cells, then it could be expected that
tumors might carry a heightened propensity to reprogram (undergo
paligenosis) in response to the injury caused by DNA-damaging
chemotherapeutic agents or radiation. Thus, plasticity within tumors
may hamper the development of targeted anti-CSC chemotherapies
to induce tumor regression because those targeted CSCs may easily
be replaced by other cells within the tumor. However, therapies
aimed at inhibiting tumor cell paligenosis may open new avenues
for treating cancer and reducing relapse.
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Clayton, E., Doupé, D. P., Klein, A. M., Winton, D. J., Simons, B. D. and
Jones, P. H. (2007). A single type of progenitor cell maintains normal epidermis.
Nature 446, 185-189.
Cole, J. W. and McKalen, A. (1963). Studies on the morphogenesis of
adenomatous polyps in the human colon. Cancer 16, 998-1002.
Collins, M. A., Yan, W., Sebolt-Leopold, J. S. and Pasca di Magliano, M. (2014).
MAPK signaling is required for dedifferentiation of acinar cells and development of
pancreatic intraepithelial neoplasia in mice.Gastroenterology 146, 822-834 e827.
Cotsarelis, G., Sun, T.-T. and Lavker, R. M. (1990). Label-retaining cells reside in
the bulge area of pilosebaceous unit: implications for follicular stem cells, hair
cycle, and skin carcinogenesis. Cell 61, 1329-1337.
Davis, H., Irshad, S., Bansal, M., Rafferty, H., Boitsova, T., Bardella, C.,
Jaeger, E., Lewis, A., Freeman-Mills, L., Giner, F. C. et al. (2015). Aberrant
epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the
stem cell niche. Nat. Med. 21, 62-70.
Deschene, E. R., Myung, P., Rompolas, P., Zito, G., Sun, T. Y., Taketo, M. M.,
Saotome, I. and Greco, V. (2014). beta-Catenin activation regulates tissue
growth non-cell autonomously in the hair stem cell niche. Science 343,
1353-1356.
de Sousa e Melo, F., Kurtova, A. V., Harnoss, J. M., Kljavin, N., Hoeck, J. D.,
Hung, J., Anderson, J. E., Storm, E. E., Modrusan, Z., Koeppen, H. et al.
(2017). A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer.
Nature 543, 676-680.
Donati, G. andWatt, F. M. (2015). Stem cell heterogeneity and plasticity in epithelia.
Cell Stem Cell 16, 465-476.
Donati, G., Rognoni, E., Hiratsuka, T., Liakath-Ali, K., Hoste, E., Kar, G.,
Kayikci, M., Russell, R., Kretzschmar, K., Mulder, K. W. et al. (2017).
Wounding induces dedifferentiation of epidermal Gata6+ cells and acquisition of
stem cell properties. Nat. Cell Biol. 19, 603-613.
Downward, J. (2003). Targeting RAS signalling pathways in cancer therapy. Nat.
Rev. Cancer 3, 11-22.
Eaden, J. A., Abrams, K. R. and Mayberry, J. F. (2001). The risk of colorectal
cancer in ulcerative colitis: a meta-analysis. Gut 48, 526-535.
Fafilek, B., Krausova, M., Vojtechova, M., Pospichalova, V., Tumova, L.,
Sloncova, E., Huranova, M., Stancikova, J., Hlavata, A., Svec, J. et al. (2013).
Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit
wnt signaling in intestinal stem cells. Gastroenterology 144, 381-391.
Fearon, E. R. and Vogelstein, B. (1990). A genetic model for colorectal
tumorigenesis. Cell 61, 759-767.
Fuchs, E. (2009). The tortoise and the hair: slow-cycling cells in the stem cell race.
Cell 137, 811-819.
Fuchs, E. and Raghavan, S. (2002). Getting under the skin of epidermal
morphogenesis. Nat. Rev. Genet. 3, 199-209.
Förstenberger, G., Rogers, M., Schnapke, R., Bauer, G., Höfler, P. andMarks, F.
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